Fannie Mae, Freddie Mac shares tumble after conservatorship comments
NEW YORK - Quest Diagnostics (NYSE:DGX) reported fourth quarter earnings and revenue that exceeded analyst expectations, while also announcing a dividend increase. However, shares edged lower in early trading.
The diagnostic testing company posted adjusted earnings per share of $2.23, beating the consensus estimate of $2.19. Revenue came in at $2.62 billion, surpassing expectations of $2.58 billion and representing a 14.5% increase YoY.
Quest Diagnostics saw robust 14.5% revenue growth in Q4, including approximately 5% organic growth. The company completed eight acquisitions in 2024, including LifeLabs in Canada, which helped drive results.
"Our guidance for 2025 reflects our confidence in the core strength of our business, continuing robust utilization, and the momentum from acquisitions completed in 2024," said Jim Davis, Chairman, CEO and President.
For full year 2025, Quest expects revenue between $10.70 billion and $10.85 billion, representing 8.4% to 9.9% growth. Adjusted EPS is forecast at $9.55 to $9.80.
The company also announced a 6.7% increase in its quarterly dividend to $0.80 per share.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.